These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15320793)

  • 1. Vascular effects of antiarrhythmic drugs and the roles of K+ channels.
    Kinoshita H; Hatano Y
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Apr; 2(2):99-106. PubMed ID: 15320793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular effects of class-III antiarrhythmic drugs: chromanol 293B, but not dofetilide blocks the smooth muscle delayed rectifier K+ channel.
    Karle CA; Bauer A; Weretka S; Zitron E; Abushi A; Kreye VA; Schoels W
    Basic Res Cardiol; 2002 Jan; 97(1):17-25. PubMed ID: 11998973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of potassium channels by antiarrhythmic and antihypertensive drugs.
    Sanguinetti MC
    Hypertension; 1992 Mar; 19(3):228-36. PubMed ID: 1548049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of cardiac potassium channels.
    Li GR; Dong MQ
    Adv Pharmacol; 2010; 59():93-134. PubMed ID: 20933200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potassium channels as pharmacological targets in cardiovascular medicine.
    Escande D; Henry P
    Eur Heart J; 1993 Jul; 14 Suppl B():2-9. PubMed ID: 8370367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of Potassium Channels in Cardiac Arrhythmias.
    Burg S; Attali B
    Trends Pharmacol Sci; 2021 Jun; 42(6):491-506. PubMed ID: 33858691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild alkalinization and acidification differentially modify the effects of lidocaine or mexiletine on vasorelaxation mediated by ATP-sensitive K+ channels.
    Kinoshita H; Iranami H; Kimoto Y; Dojo M; Hatano Y
    Anesthesiology; 2001 Jul; 95(1):200-6. PubMed ID: 11465559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockers of the ATP-sensitive potassium channel SUR2A/Kir6.2: a new approach to prevent sudden cardiac death.
    Englert HC; Heitsch H; Gerlach U; Knieps S
    Curr Med Chem Cardiovasc Hematol Agents; 2003 Oct; 1(3):253-71. PubMed ID: 15326916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class IV antiarrhythmic agents: new compounds using an old strategy.
    Szentandrássy N; Nagy D; Hegyi B; Magyar J; Bányász T; P Nánási P
    Curr Pharm Des; 2015; 21(8):977-1010. PubMed ID: 25354181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the possible involvement of Ca2+ entry blockade in the relaxation by class I antiarrhythmic drugs in the isolated pig coronary smooth muscle.
    Tanaka Y; Kamibayashi M; Yamashita Y; Imai T; Tanaka H; Nakahara T; Ishii K; Shigenobu K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):56-66. PubMed ID: 11862334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiarrhythmic actions of bisaramil and penticainide result from mixed cardiac ion channel blockade.
    Pugsley MK; Hayes ES; Saint DA; Walker MJA
    Biomed Pharmacother; 2019 Mar; 111():427-435. PubMed ID: 30594781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potassium channel openers and other regulators of KATP channels.
    Challinor-Rogers JL; McPherson GA
    Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):583-97. PubMed ID: 7813118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Potassium channels and arrhythmia].
    Funck-Brentano C
    Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():9-13. PubMed ID: 1307198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
    Tosaki A; Szerdahelyi P; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic effects of potassium channel openers.
    Haverkamp W; Borggrefe M; Breithardt G
    Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():195-202. PubMed ID: 7647023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potassium channels and human corporeal smooth muscle cell tone: diabetes and relaxation of human corpus cavernosum smooth muscle by adenosine triphosphate sensitive potassium channel openers.
    Venkateswarlu K; Giraldi A; Zhao W; Wang HZ; Melman A; Spektor M; Christ GJ
    J Urol; 2002 Jul; 168(1):355-61. PubMed ID: 12050569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of K+ channels in augmented relaxations to sodium nitroprusside induced by mexiletine in rat aortas.
    Kinoshita H; Ishikawa T; Hatano Y
    Anesthesiology; 2000 Mar; 92(3):813-20. PubMed ID: 10719960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current trends in the study of potassium channel openers.
    McPherson GA
    Gen Pharmacol; 1993 Mar; 24(2):275-81. PubMed ID: 8482511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New evolvement of antiarrhythmic drugs].
    Kanno M
    Nihon Yakurigaku Zasshi; 1993 Sep; 102(3):215-23. PubMed ID: 8406233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.